CXCL13 and neoplasm: These findings might decipher TLS, a unique immune cell architecture of the TME in HCC and TNBC with implications for previously uncharacterized roles of CXCL13-CXCR5 axis, which could act as a double-bladed sword in tumor development/progression and response to immunotherapy.